Paxil (paroxetine) and Lexapro (escitalopram) are both SSRIs, but Paxil is the older, more heavily flagged drug of the two. It carries a pregnancy warning about cardiac birth defects that Lexapro does not carry in the same way, it is widely considered the SSRI with the roughest discontinuation profile because of its short half-life, and it is the strongest CYP2D6 inhibitor in its class. This guide compares their approved uses, discontinuation risk, pregnancy safety data, side effects, and drug interactions.
This is general information, not medical advice. Never stop Paxil abruptly; its discontinuation effects are among the most pronounced of any SSRI.
Paxil vs Lexapro at a glance
| Paxil (paroxetine) | Lexapro (escitalopram) | |
|---|---|---|
| Drug class | SSRI | SSRI |
| FDA-approved for | MDD, OCD, panic disorder, social anxiety disorder, GAD, PTSD | MDD (adults and adolescents 12-17), GAD (adults) |
| Half-life | About 21 hours, but its own metabolism inhibits its own clearance at higher doses | About 27-32 hours |
| Discontinuation risk | High; among the most pronounced of any SSRI | Moderate |
| Pregnancy | FDA warning: increased risk of cardiac malformations with first-trimester use | No comparable specific cardiac malformation warning |
| CYP2D6 inhibition | Strongest among SSRIs | Weaker than paroxetine |
| Weight and sedation | More associated with weight gain and sedation | Less sedating in general use |
What each is approved for
Paxil has one of the broadest indication lists among SSRIs: major depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and post-traumatic stress disorder.
Lexapro is narrower: major depressive disorder in adults and adolescents 12 to 17, and generalized anxiety disorder in adults.
If the diagnosis is OCD, panic disorder, social anxiety disorder, or PTSD specifically, Paxil has an approved indication that Lexapro does not.
Why paroxetine’s pharmacokinetics matter
Paroxetine has an unusual pharmacokinetic quirk: it inhibits its own metabolism. As the dose increases, its clearance from the body slows in a non-linear way, meaning small dose increases can produce disproportionately larger increases in blood levels. This, combined with a relatively short overall half-life once steady state is disrupted, contributes to paroxetine having a reputation as the SSRI most associated with a rough discontinuation experience if a dose is missed or the drug is stopped abruptly.
Escitalopram has more predictable, linear pharmacokinetics and a moderate half-life, without this self-inhibiting quirk.
Discontinuation syndrome: Paxil’s defining risk
Among SSRIs, paroxetine is widely regarded, in both clinical experience and published reviews, as carrying the most pronounced discontinuation syndrome. Symptoms after even a missed dose or two can include dizziness, “brain zap” sensations, irritability, flu-like symptoms, vivid dreams, and a general sense of unwellness, sometimes appearing within a day of a missed dose given its relatively short effective half-life at steady state.
This has real practical implications:
- Missing even one or two doses of Paxil is more likely to cause noticeable symptoms than missing doses of Lexapro.
- Stopping Paxil requires a slow, carefully planned taper, often slower than for other SSRIs.
- People who travel, have irregular schedules, or have struggled with adherence to other medicines may find Paxil especially challenging.
Escitalopram can also cause discontinuation symptoms if stopped abruptly, and a gradual taper is recommended for it too, but it is generally considered less severe in this regard than paroxetine.
Pregnancy: a key difference
This is one of the more consequential differences between the two drugs. The FDA has specifically flagged paroxetine with warnings about increased risk of certain birth defects, particularly cardiac malformations, when taken during the first trimester of pregnancy, based on epidemiological studies. This has led many guidelines to recommend avoiding paroxetine specifically in women who are pregnant or planning pregnancy, when a reasonable alternative exists.
Escitalopram does not carry a comparable specific cardiac malformation warning, though as with all antidepressants in pregnancy, the decision to start, continue, or switch is individualized, weighing the risks of untreated depression or anxiety against medication risks. Anyone taking paroxetine who becomes pregnant or is planning to should discuss this specific warning with their obstetrician and psychiatrist promptly, rather than stopping the drug abruptly on their own, given paroxetine’s discontinuation profile.
Side effects
Both drugs share the standard SSRI side-effect list: nausea, sexual side effects, sweating, and sleep changes. Beyond that overlap, some differences are commonly reported:
- Sedation. Paroxetine is generally considered more sedating than escitalopram, and it has some mild anticholinergic-like effects (dry mouth, constipation) not typical of most other SSRIs.
- Weight gain. Paroxetine has a stronger association with weight gain in long-term use compared with several other SSRIs, including escitalopram.
- QT prolongation. Escitalopram carries a specific dose-related QT-prolongation warning capping its maximum dose at 20 mg (10 mg in older adults); paroxetine’s label does not emphasize this particular cardiac electrical warning to the same degree, though all SSRIs warrant some caution in patients with cardiac risk factors.
Drug interactions: paroxetine’s strong CYP2D6 inhibition
Paroxetine is considered the strongest CYP2D6 inhibitor among the SSRIs, meaning it has the greatest potential to raise blood levels of other drugs cleared by that liver enzyme, including tamoxifen (where the interaction is clinically important, since paroxetine can reduce tamoxifen’s effectiveness by blocking its activation), certain heart medicines, and other antidepressants. Escitalopram has a comparatively milder effect on CYP2D6.
Both drugs are contraindicated with MAOIs, requiring a standard 14-day washout period, and both raise serotonin syndrome risk when combined with other serotonergic drugs, and bleeding risk when combined with NSAIDs, aspirin, or anticoagulants.
Tapering off Paxil safely
Because of its discontinuation profile, stopping Paxil deserves specific planning:
- Never stop abruptly, even if you feel well, unless a prescriber has advised otherwise for a medical reason.
- Expect a slower taper than you might assume. Many prescribers reduce the dose in smaller steps and over a longer period for paroxetine than they would for other SSRIs, sometimes using liquid formulations or dose splitting to achieve small enough steps.
- Know the symptoms so you do not mistake discontinuation effects for a return of your original condition: dizziness, “brain zap” sensations (brief electric-shock feelings, often with eye movement), irritability, nausea, vivid dreams, and flu-like achiness are typical.
- If you miss doses often because of a busy schedule, tell your prescriber. This is one of the strongest practical reasons to consider a different SSRI upfront rather than discovering the problem after starting Paxil.
- A switch to fluoxetine (Prozac) is sometimes used clinically as a bridging strategy when stopping paroxetine, since fluoxetine’s long half-life smooths out the transition, though this is a specialist decision.
Dosing overview
Paxil dosing varies by indication. For depression, the typical starting dose is 20 mg once daily, with increases in 10 mg increments if needed, up to a maximum around 50 mg daily depending on response and tolerability. For panic disorder, dosing sometimes starts lower (10 mg) given a tendency toward early jitteriness. Controlled-release formulations (Paxil CR) exist with different starting doses.
Lexapro starts at 10 mg once daily for both depression and generalized anxiety disorder, increasing to a maximum of 20 mg after at least one week if needed, with 10 mg as the maximum recommended dose in older adults.
Practical questions people ask
“I’ve been on Paxil for years and want to switch. Is it worth the discontinuation risk?” This is a decision for your prescriber, weighing how well Paxil is working, why you want to switch, and how the taper would be managed. Many people successfully switch SSRIs with proper planning; it is not a reason to avoid ever changing medications, but it does mean the switch should be planned rather than done abruptly.
“Does Paxil’s pregnancy warning mean I have to stop if I get pregnant unexpectedly?” No. This is exactly the situation to bring to your obstetrician and psychiatrist promptly rather than stopping on your own, since abrupt discontinuation carries its own risks, including relapse and, specifically with paroxetine, discontinuation symptoms. The decision about continuing, switching, or adjusting is individualized.
“Is generic paroxetine the same as brand Paxil?” Yes, generic paroxetine contains the same active ingredient and is subject to the same FDA bioequivalence standards.
Who each might suit
Factors that may point toward Paxil:
- OCD, panic disorder, social anxiety disorder, or PTSD as the primary diagnosis
- A need for a somewhat more sedating profile, in cases where that is desired at bedtime
- No plans for pregnancy in the near term, and no interacting medicine cleared by CYP2D6 (such as tamoxifen)
Factors that may point toward Lexapro:
- Pregnancy, or plans for pregnancy, where avoiding paroxetine’s specific cardiac malformation warning is a priority
- A history of difficulty with missed doses or adherence, given Paxil’s harsher discontinuation profile
- Concurrent use of tamoxifen or another CYP2D6-dependent medicine
- A teenager 12 to 17 with depression, since Lexapro has that specific pediatric indication and Paxil’s pediatric use is more restricted
Frequently asked questions
Why is Paxil harder to stop than Lexapro?
Paroxetine’s pharmacokinetics, including a relatively short effective half-life and a tendency to inhibit its own metabolism, make it widely regarded as the SSRI with the most pronounced discontinuation syndrome. A slow, supervised taper is important when stopping it.
Is Paxil safe during pregnancy?
The FDA has specifically warned about an increased risk of cardiac birth defects with first-trimester paroxetine use, and many guidelines recommend avoiding it in pregnancy when an alternative exists. This decision should be made with an obstetrician and psychiatrist, not by stopping the drug abruptly.
Which causes more weight gain, Paxil or Lexapro?
Paroxetine has a stronger association with weight gain in long-term use compared with escitalopram, based on clinical experience and comparative data.
Can I take tamoxifen with Paxil?
This combination is generally discouraged because paroxetine, as the strongest CYP2D6 inhibitor among SSRIs, can reduce tamoxifen’s effectiveness by blocking the enzyme that activates it. Discuss alternatives with your oncology and psychiatric teams.
Is Lexapro better than Paxil?
Neither is universally “better.” Paxil has a broader indication list and may be more sedating, useful for some patients, but carries a rougher discontinuation profile and a specific pregnancy warning. Lexapro is narrower in approved use but generally easier to stop and lacks that particular pregnancy warning.
How long does Paxil withdrawal last?
It varies by individual and how long someone has been on the drug, but symptoms can begin within a day or two of a missed dose and may take weeks to fully resolve during a proper taper. A slow, prescriber-guided taper reduces the severity and duration.